Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-16-000527
Filing Date
2016-10-05
Accepted
2016-10-05 18:24:46
Documents
2
Period of Report
2016-10-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4032
2 POA lemasters_poa.txt EX-24 2956
  Complete submission text file 0001190725-16-000527.txt   8421
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
LEMASTERS CHRISTOPHER C. (Reporting) CIK: 0001685304 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 161923550